Olaplex Q3 sales beat estimates

Olaplex Holdings

06/11/2025 11:56

Overview

Olaplex Q3 net sales decreased 3.8% yr/yr but beat analyst expectations

Adjusted EBITDA for Q3 beat analyst expectations

Net income for Q3 decreased 24.8% yr/yr

Outlook

Olaplex reaffirms fiscal 2025 net sales guidance of $410 mln to $431 mln

Company expects adjusted gross profit margin of 70.5% to 71.5% for 2025

Olaplex anticipates adjusted EBITDA margin of 20% to 22% for fiscal 2025

Result Drivers

SALES CHANNEL PERFORMANCE - Specialty Retail and Direct-To-Consumer sales declined, while Professional channel sales increased

INTERNATIONAL GROWTH - Net sales increased 7.1% internationally, offsetting some U.S. declines

INVESTMENTS AND PRODUCT LAUNCHES - Co attributes results to investments in sales, marketing, and new product introductions

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Beat
$114.58 mln
$110.59 mln (6 Analysts)
Q3 EPS
$0.02
Q3 Adjusted EBITDA
Beat
$30.79 mln
$27.93 mln (7 Analysts)
Q3 Adjusted EBITDA Margin
26.90%
Q3 Gross Profit
$79.20 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 7 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the personal products peer group is "buy."

Wall Street's median 12-month price target for Olaplex Holdings Inc is $1.75, about 39.4% above its November 5 closing price of $1.06

The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 19 three months ago

Press Release: ID:nGNX3ztk54

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)